iPS cells are moving from clinical trialsーeye disease, Parkinson’s disease, heart failure, cancer, spinal cord injuriesーto the stage of practical application.
A team of researchers led by Osaka University Professor Koji Nishida has successfully treated an eye disease patient by transplanting artificially-cultured corneal cells derived from...